Skip to content
Skip to main content
Call Us Today Request a Specification

Sector

Pharmaceutical Manufacturing

Pharmaceutical manufacturers commission ISO 14644 cleanroom-classified epoxy systems with ESD compliance.

Why Pharmaceutical Manufacturing Specifies Epoxy GH

Pharmaceutical manufacturing environments operate under a regulatory burden that few other facility types match. Every surface within a cleanroom classification zone — from ISO Class 7 filling suites to ISO Class 8 packaging halls — must demonstrate chemical resistance, particle-shedding control, and seamless hygienic integrity across its entire service life. Epoxy GH has served pharmaceutical and life-sciences facilities across Ghana since 1981, delivering specification-grade epoxy systems engineered to satisfy the exacting standards that qualified-person sign-off and regulatory inspection demand.

The consequences of surface failure in a pharmaceutical environment extend well beyond maintenance cost. A delaminating floor or a porous wall coating becomes a contamination vector, a batch-release liability, and a regulatory finding. Clients in this sector specify Epoxy GH precisely because 45 years of institutional practice has refined our application methodology, primer sequencing, and curing protocols to a standard that holds under pharmaceutical-grade scrutiny.

Specification Requirements Unique to Pharmaceutical Manufacturing

Pharmaceutical facilities present a compound specification challenge: cleanroom classification under ISO 14644-1 governs permissible particle counts, which in turn dictates surface texture thresholds and seam-free construction requirements. Simultaneously, electrostatic discharge (ESD) compliance is mandatory in areas handling active pharmaceutical ingredients (APIs) prone to dust ignition risk, or where sensitive electronic dispensing equipment is deployed. Epoxy GH systems are engineered to deliver surface resistivity within the ATEX-aligned and IEC 61340-compliant ranges without sacrificing the chemical resistance required by GMP-regulated cleaning regimens.

Beyond electrostatics, pharmaceutical clients must satisfy WHO Good Manufacturing Practice (GMP) and Ghana Food and Drugs Authority (FDA) facility standards, which mandate non-porous, non-reactive, and readily decontaminable surfaces. Coving profiles, floor-to-wall junctions, and drain surrounds receive the same specification rigour as primary floor fields — there are no secondary surfaces in a regulated pharmaceutical environment.

Notable Project Types

Pharmaceutical manufacturing commissions handled by Epoxy GH typically span new-build production facilities and the remediation of existing GMP zones undergoing re-qualification. A representative scope pattern involves a multi-zone production facility on the Tema Industrial Corridor — comprising ISO Class 7 and Class 8 classified production suites, an API dispensing room with full ESD floor specification, and a utilities corridor requiring chemical-resistant coating to withstand repeated caustic washdowns. Total floor and wall coverage on projects of this category commonly ranges from 800 to 3,500 square metres, with installation sequenced to accommodate validation timelines and minimise disruption to adjacent production areas.

Warehouse and cold-chain annexes to pharmaceutical production facilities present a complementary scope: high-bay storage areas with heavy pallet-racking loads demand a screed system of sufficient compressive strength, while cold-store antechambers require moisture-tolerant primer systems and thermal-cycling-resistant topcoats — a specification configuration well within Epoxy GH’s standard pharmaceutical offering.

Compliance & Standards